Susanne Magnusson

Susanne Magnusson has a wealth of experience in the medical and scientific fields. Susanne has been working since 2007, starting as a MSc and PhD student at Lund University, where they were responsible for initiating and establishing a new research program focused on childhood cancer and genetic predisposition. Susanne then worked as a Post Doc at Lund University, where their key tasks included project management, supervising, critical data evaluation and statistical analysis, compilation and graphic presentation of data, and writing of scientific papers, research applications and applications to authorities.

In 2013, they began working for Enzymatica AB as a Senior Scientist, where they were responsible for evaluating and designing strategy for a new application for a class II device within a new indication area for the company's enzyme-based formulation. That same year, they also began working for BioActive Polymers in Lund AB as a Project Manager & QA/RA Manager, where they were responsible for strategy development, coordination of GMP-production and pre-clinical studies, applications for clinical trials to authorities, management of clinical sites and clinicians, reporting, and overall accountability for quality and regulatory affairs.

In 2017, they began working for Cantargia AB as a Director Clinical Development and Associate Director Development.

Susanne Magnusson obtained their Doctor of Philosophy (PhD) in Clinical Medicine and Experimental Oncology from Lund University in 2012, having previously obtained their MSc in Biomedicine from Lund University in 2007. Susanne also attended Spykens Gymnasieskola from 1999 to 2002. No additional certifications are listed.